![]() The global Hernia Repair Market is expected to reach USD 6.60 billion by 2024. Rigorous research & development activities, growing number of obese patients and high susceptibility of geriatric patients to suffer from hernia are expected to drive the market over the forecast period. Increasing technological sophistication in repair devices and rigorous research and development of the drug-eluting mesh is projected to boost the demand for hernia repair devices and consumables. Post-operative pain is growing concern post-repair with synthetic mesh. Though the cause of pain varies from patient to patient, a primary reason for pain is inflammation associated with the synthetic mesh. Other chronic illnesses related to the use of implanted mesh are abdominal pain, infection (sepsis), bowel obstruction and adhesion. In spite of increasing technological sophistication in mesh technology, synthetic materials remain the most widely used mesh products for hernia repair especially the polypropylene mesh due to their low cost and easy availability. The biological mesh is gaining momentum in developed countries especially in the U.S. Biologic mesh development has overcome the problem associated the synthetic mesh including foreign body interaction, chronic inflammation, infection, and stiffness. Presence of favorable reimbursement policies coupled with the well-regulated healthcare insurance and increasing prevalence of an inguinal and ventral hernia in developed economies have rendered increased acceptance of this product. Browse Details of Report @ https://www.hexaresearch.com/research-report/hernia-repair-market The above mentioned factors collectively boost demand for overall hernia repair consumables and surgical devices market over the forecast period. Owing to shortcomings of synthetic mesh, manufacturers are working on developing cost-effective and technological advanced mesh. For instance, Ariste Medical is developing drug-eluting mesh. These repair products are anticipated to improve the patient outcomes specifically in vascular procedures including hernia and peripheral bypass hemodialysis processes. Also, manufacturers are focusing on developing composite or hybrid mesh. The hybrid mesh is a result of the combination of best features of biologic and synthetic mesh. Mesh that combines a minute quantity of synthetic material such as polypropylene and biologic building blocks derived from animal tissue has the property to diminish the hazards of inflammatory reactions along with providing long-term durability. Medtronic and COOK Medical are investing in the development of cost-effective composite mesh. This product may overcome the disadvantages associated with the synthetic mesh such as inflammation, sepsis and abdominal adhesion. These factors render cost advantage over the biologic mesh, which in turn is expected to boost the hernia repair market. Hexa Research has segmented the global hernia repair market based on product, procedure, and region: Segmentation by product, 2014 - 2024 (USD Million) • Consumables • Synthetic Mesh • Biologic Mesh • Surgical Devices Segmentation by procedure, 2014 - 2024 (USD Million) • Tension Free • Open Hernia Repair • Laparoscopic Segmentation by region, 2014 - 2024 (USD Million) • North America • U.S. • Europe • Germany • Asia Pacific • China • Central & South America • Brazil • Middle East & Africa • UAE Key players analyzed: • Ethicon, Inc. • Medtronic • C. R. Bard • Atrium Browse Related Category Market Reports @ https://www.hexaresearch.com/research-category/medical-devices-industry About Us: Hexa Research is a market research and consulting organization, offering industry reports, custom research and consulting services to a host of key industries across the globe. We offer comprehensive business intelligence in the form of industry reports which help our clients obtain clarity about their business environment and enable them to undertake strategic growth initiatives. Contact Us: Ryan Shaw Hexa Research Felton Office Plaza 6265 Highway 9 Felton, California 95018 United States Phone: +1-800-489-3075 Email: [email protected] Website - https://www.hexaresearch.com/
0 Comments
![]() The global Ultrasound Device Market was worth USD 6.9 billion in 2015. It is projected to grow at a CAGR of 7% from 2016 to 2024 (forecast period). Chief market drivers are increasing incidences of chronic and hypertension related disorders. Ultrasound technology is used to treat prostate cancer and kidney stones. It is the most preferred mode of fetal screening across the globe. Trials are underway to find novel applications like detecting breast fibroadenoma and uterine fibroids. This coupled with escalating public-private investments would create opportunities for ultrasound devices. The market is segmented as per products, portability, and regions. Products are split into diagnostic ultrasound devices and therapeutic ultrasound devices. Diagnostic ultrasound devices are further segmented into 2D devices and 3D/4D devices. They accounted for the largest market share in 2015 due to a variety of applications in radiology, obstetrics, and oncology. Therapeutic ultrasound devices include HIFU (High Intensity Focused Ultrasound) and ESWL Extracorporeal Shockwave Lithotripsy). Based on portability, the market is divided into handheld devices and cart/trolley based devices. Handheld devices are expected to grow as a result of increasing preference for home healthcare and remote patient monitoring. They are likely to grow at a CAGR of 6.5% over the forecast period. Browse Details of Report@ https://www.hexaresearch.com/research-report/ultrasound-device-market Regional segmentation encompasses Europe, North America, Asia Pacific, MEA (Middle East & Africa) and Latin America. North America was the leading region (26% revenue share) in 2014. Key regional drivers include a well-established healthcare system, and rising preference for remote healthcare. Advanced technology in this region is also creating demand for miniature user-friendly devices. Asia Pacific should also grow lucratively during the forecast period. Presence of large industry players in Japan and China contributes to the same. Moreover, this region is home to highly populous countries like China and India. These and other developing nations are creating a large customer of pool for various ailments requiring ultrasound screening. These factors will result in the Asia Pacific market growing at a CAGR of 9.7% in the eight years ahead. Prominent participants in the global ultrasound devices market include Hitachi Medical Corporation, Siemens Healthcare GmbH, Samsung Medison, and Toshiba Medical Systems Corporation. Browse Related Category Market Reports@ https://www.hexaresearch.com/research-category/medical-devices-industry About Us: Hexa Research is a market research and consulting organization, offering industry reports, custom research and consulting services to a host of key industries across the globe. We offer comprehensive business intelligence in the form of industry reports which help our clients obtain clarity about their business environment and enable them to undertake strategic growth initiatives. Contact Us: Ryan Shaw Hexa Research Felton Office Plaza 6265 Highway 9 Felton, California 95018 United States Phone: +1-800-489-3075 Email: [email protected] Website - http://www.hexaresearch.com/ ![]() A recent study by Hexa Research revealed that limited range of treatment choices relating to medical conditions like epilepsy, Alzheimer’s disease, Parkinson’s disease, migraine headaches, etc. is one of the key drivers of the global Neurostimulation Devices Market. An upcoming application area is the use of neurostimulation devices for therapeutic purposes, commonly referred to as neuromodulation. The neurostimulation devices market is benefitting from technological advancements like the transdermal neuromodulation technology by Neurowave Medical Technologies and MRI safety-enabled devices by Medtronics, Inc. Rising elderly populace - a high risk demographic for Parkinson’s and Alzheimer’s, is also driving market growth. Accelerated demand for neurostimulation devices in the future years is expected to result from untapped market opportunities in emerging economies of Asia as well as Latin America and the growing number of externally funded clinical programs for development of new products. Browse Details of Report @ https://www.hexaresearch.com/research-report/neurostimulation-devices-industry/ Hexa Research identifies spinal cord stimulation devices, vagus nerve stimulation devices, gastric electric stimulation devices, deep brain stimulation devices, and sacral nerve stimulation devices to be the key product segments in the neurostimulation devices market. Spinal cord stimulation devices, with a contribution of more than half to the total revenues, were the dominant product segment in 2012. Pain management proved to be the largest application of neurostimulation devices in 2012 and contributed more than 65% to the total demand that year. This was chiefly due to high incidence of conditions characterized by chronic pain and notable therapeutic effects offered by neurostimulation devices. While North America contributed around 64% to the total revenues in 2012, Asia Pacific is likely to grow the fastest in future. Fast-developing economies like India and China will result in the Asia Pacific neurostimulation devices market growing at CAGR higher than 16% from 2013 to 2020. Hexa Research observes that the neurostimulation devices industry exhibits outsourcing of expensive manufacturing activities. This enables industry participants to achieve cost efficiency and better profitability. Key industry players include Boston Scientific Corporation, Cyberonics, Medtronic Inc., and St. Jude Medical. Browse Related Category Market Reports @ https://www.hexaresearch.com/research-category/healthcare-industry About Us: Hexa Research is a market research and consulting organization, offering industry reports, custom research and consulting services to a host of key industries across the globe. We offer comprehensive business intelligence in the form of industry reports which help our clients obtain clarity about their business environment and enable them to undertake strategic growth initiatives. Contact Us: Ryan Shaw Hexa Research Felton Office Plaza 6265 Highway 9 Felton, California 95018 United States Phone: +1-800-489-3075 Email: [email protected] Website - http://www.hexaresearch.com/ ![]() The global Visceral Pain Market is expected to reach USD 14.22 billion by 2024, driven by the increasing geriatric population globally. Increasing prevalence of visceral pain and rising awareness regarding the same is projected to drive market growth over the forecast period. In 2016, North America held the majority of share in global visceral pain market owing to the increasing healthcare expenditure. Additionally, the high prevalence of Crohn’s and irritable bowel is expected to propel the growth of the market over the projected period. Asia Pacific is expected to be the fastest growing region with the CAGR of 6.2%. The increase in the healthcare infrastructure and presence of a large pool of patients is projected to drive the demand for the visceral pain industry during the forecast period. Analgesic segment dominated the market for the visceral pain with the market share of 60.4%. The major share of the analgesic segment is attributed to the increasing penetration of generic drug. Furthermore, rising healthcare expenditure and an increasing use of opioids for the chronic pain are the key factors attributing to its share. Browse Details of Report @ https://www.hexaresearch.com/research-report/visceral-pain-market In 2016, Crohn’s disease was the largest indication segment for the visceral pain market contributing to 41.4% of the market share. Increasing occurrences of Crohn’s disease across the globe coupled with the growing drug therapies for the treatment of the disease are the key factors attributing to the major share. Furthermore, increasing awareness about Crohn’s disease is fueling the demand for treatment therapies. Key market players include Pfizer, Johnson & Johnson, Abbvie, Takeda, Allergan, and AstraZeneca. These companies are focusing on R&D for visceral pain therapeutics. These companies are likely to cater their products to patients affected by visceral pain. The growth of the geriatric population is expected to help in augmenting the profits of these companies over the next few years. Growing focus on research and development by pharmaceutical companies and government initiatives are expected to boost the visceral pain industry during the forecast period. The market is projected to witness significant gain during the forecast period owing to increasing collaboration within pharmaceutical companies. Also, factors such as increasing awareness among people regarding visceral pain are further anticipated to propel the market growth. Hexa Research has segmented the global visceral pain market on the basis of therapeutics, indications and region: Segmentation by therapeutics, 2014 - 2024 (USD Million) • Analgesics • Narcotics • NSAID • Pain modifiers • Tricyclic Antidepressants • Tricyclic Anticonvulsant • Others Segmentation by indications, 2014 - 2024 (USD Million) • Interstitial cystitis • Crohn’s • Irritable bowel • Chronic prostatitis Segmentation by region, 2014 - 2024 (USD Million) • North America • Europe • Asia Pacific • Rest of the World (RoW) Key players analyzed: • Pfizer Inc. • Allergan • Johnson & Johnson • Bayer AG • Takeda Pharmaceutical Company Limited • Mallinkrodt Pharmaceuticals • AbbVie Inc. • AstraZeneca Browse Related Category Market Reports @ https://www.hexaresearch.com/research-category/clinical-diagnostics-industry About Us: Hexa Research is a market research and consulting organization, offering industry reports, custom research and consulting services to a host of key industries across the globe. We offer comprehensive business intelligence in the form of industry reports which help our clients obtain clarity about their business environment and enable them to undertake strategic growth initiatives. Contact Us: Ryan Shaw Hexa Research Felton Office Plaza 6265 Highway 9 Felton, California 95018 United States Phone: +1-800-489-3075 Email: [email protected] Website - https://www.hexaresearch.com |
Archives
October 2023
|